Serum, urine and peritoneal fluid levels of 5-FU following intraperitoneal administration. 1987

E Campora, and M Esposito, and D Civalleri, and L Gogioso, and F Decian, and N Balletto, and A Falcone, and M T Nobile, and B Parodi, and S Cafaggi
Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.

Seven patients with advanced colon cancer, refractory to conventional chemotherapy, and malignant disease confined to the intra-abdominal space received a total of 24 consecutive courses of ip 5-Fluorouracil (5-FU). 5-FU 1000 mg was administered in 2 L of warm (37 degrees C) dialysate daily for five consecutive days every 28 days. 5-FU concentrations in serum, peritoneal fluid and urine were measured by high pressure liquid chromatography (HPLC). The mean disappearance half-life of 5-FU from the peritoneal fluid was 1.6 hours with a mean permeability area product (PA) of 22.4 ml/min. The mean peritoneal AUC was 450 +/- 165 times greater than the mean serum AUC. Ip 5-FU treatment is well tolerated, can be safely administered on an outpatient basis and produces a significant pharmacological advantage over conventional routes of administration.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002404 Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. Cannulation,Cannulations,Catheterizations
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001202 Ascitic Fluid The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY. Peritoneal Effusion,Peritoneal Fluid,Ascitic Fluids,Effusion, Peritoneal,Fluid, Ascitic,Fluid, Peritoneal,Peritoneal Effusions,Peritoneal Fluids

Related Publications

E Campora, and M Esposito, and D Civalleri, and L Gogioso, and F Decian, and N Balletto, and A Falcone, and M T Nobile, and B Parodi, and S Cafaggi
February 1955, Acta chirurgica Scandinavica,
E Campora, and M Esposito, and D Civalleri, and L Gogioso, and F Decian, and N Balletto, and A Falcone, and M T Nobile, and B Parodi, and S Cafaggi
January 1990, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition,
E Campora, and M Esposito, and D Civalleri, and L Gogioso, and F Decian, and N Balletto, and A Falcone, and M T Nobile, and B Parodi, and S Cafaggi
September 1991, Zhonghua zhong liu za zhi [Chinese journal of oncology],
E Campora, and M Esposito, and D Civalleri, and L Gogioso, and F Decian, and N Balletto, and A Falcone, and M T Nobile, and B Parodi, and S Cafaggi
November 1997, Gan to kagaku ryoho. Cancer & chemotherapy,
E Campora, and M Esposito, and D Civalleri, and L Gogioso, and F Decian, and N Balletto, and A Falcone, and M T Nobile, and B Parodi, and S Cafaggi
January 1976, Annali Sclavo; rivista di microbiologia e di immunologia,
E Campora, and M Esposito, and D Civalleri, and L Gogioso, and F Decian, and N Balletto, and A Falcone, and M T Nobile, and B Parodi, and S Cafaggi
October 1999, Gan to kagaku ryoho. Cancer & chemotherapy,
E Campora, and M Esposito, and D Civalleri, and L Gogioso, and F Decian, and N Balletto, and A Falcone, and M T Nobile, and B Parodi, and S Cafaggi
October 1981, American journal of veterinary research,
E Campora, and M Esposito, and D Civalleri, and L Gogioso, and F Decian, and N Balletto, and A Falcone, and M T Nobile, and B Parodi, and S Cafaggi
October 1981, American journal of veterinary research,
E Campora, and M Esposito, and D Civalleri, and L Gogioso, and F Decian, and N Balletto, and A Falcone, and M T Nobile, and B Parodi, and S Cafaggi
September 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
E Campora, and M Esposito, and D Civalleri, and L Gogioso, and F Decian, and N Balletto, and A Falcone, and M T Nobile, and B Parodi, and S Cafaggi
February 1970, The Journal of urology,
Copied contents to your clipboard!